Literature DB >> 4314823

Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.

A S Rose, J W Kuzma, J F Kurtzke, N S Namerow, W A Sibley, W W Tourtellotte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4314823     DOI： 10.1212/wnl.20.5_part_2.1

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  54 in total

1.  Reviewing multiple sclerosis.

Authors:  A Compston
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  A battery of tests for evaluating steadiness in clinical trials.

Authors:  A R Potvin; J W Albers; R F Stribley; W W Tourtellotte; R W Pew
Journal:  Med Biol Eng       Date:  1975-11

3.  Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.

Authors:  E M Lance; M Kremer; J Abbosh; V E Jones; S Knight; P B Medawar
Journal:  Clin Exp Immunol       Date:  1975-07       Impact factor: 4.330

4.  Neurology-epitomes of progress: treatment of multiple sclerosis with adrenal cortical steroids.

Authors:  J R Nelson
Journal:  West J Med       Date:  1977-08

5.  Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.

Authors:  Amy Perrin Ross; June Halper; Colleen J Harris
Journal:  Int J MS Care       Date:  2012

Review 6.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

7.  Intravenous methylprednisolone for multiple sclerosis in relapse.

Authors:  M P Barnes; D E Bateman; P G Cleland; D J Dick; T J Walls; P K Newman; M Saunders; P J Tilley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-02       Impact factor: 10.154

Review 8.  Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.

Authors:  Regina Berkovich; Mark A Agius
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

Review 9.  Managing advanced multiple sclerosis.

Authors:  R W Teasell
Journal:  Can Fam Physician       Date:  1993-05       Impact factor: 3.275

Review 10.  Treatment of acute relapses in multiple sclerosis.

Authors:  Regina Berkovich
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.